Latest Breaking News On - Austria based origimm - Page 1 : comparemela.com

Sanofi’s strategy to develop new messenger RNA vaccines is adding another piece. The pharmaceutical giant struck a deal to acquire Origimm Biotechnology, a startup developing therapeutic vaccines to treat skin diseases and infections.

Sanja selakRna centerOrigimm biotechnologyAustria based origimmParis based sanofiTranslate bioWeight lossMedical devicesHealthcare innovationMedcity newsMedcity newsSan franciscoLife sciencesRock healthStartup adviceStartup funding